en
ua
en
EGW-NewsDota 2All news#helpflow: Double Dimension player has been diagnosed with cancer

#helpflow: Double Dimension player has been diagnosed with cancer

0
0
2802

Double Dimension player,  Alexander «Flow» Sazonov, was diagnosed with mediastinal tumor, a cancer tumor with poor prognosis. At the beginning of February, the player will have a surgery that costs about 2,000,000 RUB (about $35,000).

Official announcement with the payment details of the player:

Farmskins

Sign up now and get 2 FREE CASES + 5$ Bonus

Farmskins
CS:GO
Claim bonus
CSGOLuck

3 Free Cases + 100% up to 100 Coins on First Deposit

CSGOLuck
CS:GO
Claim bonus
Chicken.gg

Free gems, plus daily, weekly, & monthly boosts!

Chicken.gg
CS:GO
Claim bonus

«At the beginning of February, Aleksandr will get a surgery, he will be cut out the tumor. Currently, it has 21sm in diameter. It pressures heart, lunges, and bronchus. The surgery is complicated, and there are too many risks. The surgery itself is free, but the labs, drugs, rehabilitation – all these costs too much. Besides, we don’t know whether the surgery will be successful enough as the player may need an additional round of chemo and several more surgeries. It’s hard to tell how much the treatment will cost, but the doctors tell it will be about 2 000 000 RUB. Sasha did not want to ask the community for a help until recently, but the lack of money forces him to do that.

So let’s put our efforts together and help Sasha to beat the disease, as the playing community is one of the most cohesive ones.

Sasha will be grateful for any help – repost, some money, or words for support.

Sperbank: 676196000095744828, recipient - Александр Сергеевич С. / Aleksandr Sergeevich S.Tinkofff: 4377 7200 0012 8025QIWI: +79661573434PayPal: [email protected]Yandex.Money: 410015028674796»

 

It’s obvious that the player has been moved to reserve for an unlimited period.

Leave comment
Did you like the article?
0
0

More about teams:

Double DimensionDouble DimensionEGW

Comments

BRING TO TOP
FREE SUBSCRIPTION ON EXCLUSIVE CONTENT
Receive a selection of the most important and up-to-date news in the industry.
*
*Only important news, no spam.
SUBSCRIBE
LATER
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic.
Customize
OK